152 related articles for article (PubMed ID: 37841109)
21. Pilot study on the uptake and modification of harmaline in acceptor plants: An innovative approach to visualize the interspecific transfer of natural products.
Lewerenz L; Hijazin T; Abouzeid S; Hänsch R; Selmar D
Phytochemistry; 2020 Jun; 174():112362. PubMed ID: 32229335
[TBL] [Abstract][Full Text] [Related]
22. Hispidin, Harmaline, and Harmine as potent inhibitors of bovine xanthine oxidase: Gout treatment, in vitro, ADMET prediction, and SAR studies.
Linani A; Benarous K; Bou-Salah L; Yousfi M
Bioorg Chem; 2021 Jul; 112():104937. PubMed ID: 33932770
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human cytochrome P450 enzymes 3A4 and 2D6 by β-carboline alkaloids, harmine derivatives.
Zhao T; He YQ; Wang J; Ding KM; Wang CH; Wang ZT
Phytother Res; 2011 Nov; 25(11):1671-7. PubMed ID: 21433154
[TBL] [Abstract][Full Text] [Related]
24. Comparative study on the vasorelaxant effects of three harmala alkaloids in vitro.
Shi CC; Liao JF; Chen CF
Jpn J Pharmacol; 2001 Mar; 85(3):299-305. PubMed ID: 11325023
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca.
Callaway JC; Raymon LP; Hearn WL; McKenna DJ; Grob CS; Brito GS; Mash DC
J Anal Toxicol; 1996 Oct; 20(6):492-7. PubMed ID: 8889686
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular actions of three harmala alkaloids: harmine, harmaline, and harmalol.
Aarons DH; Rossi GV; Orzechowski RF
J Pharm Sci; 1977 Sep; 66(9):1244-8. PubMed ID: 903860
[TBL] [Abstract][Full Text] [Related]
27. Targeting different RNA motifs by beta carboline alkaloid, harmalol: a comparative photophysical, calorimetric, and molecular docking approach.
Bhattacharjee P; Sarkar S; Pandya P; Bhadra K
J Biomol Struct Dyn; 2016 Dec; 34(12):2722-2740. PubMed ID: 26629671
[TBL] [Abstract][Full Text] [Related]
28. Spectroscopic and structural studies on the interaction of an anticancer β-carboline alkaloid, harmine with GC and AT specific DNA oligonucleotides.
Sharma S; Yadav M; Gupta SP; Pandav K; Kumar S
Chem Biol Interact; 2016 Dec; 260():256-262. PubMed ID: 27590873
[TBL] [Abstract][Full Text] [Related]
29. Recent pharmacological developments in β-carboline alkaloid "harmaline".
Khan FA; Maalik A; Iqbal Z; Malik I
Eur J Pharmacol; 2013 Dec; 721(1-3):391-4. PubMed ID: 23707188
[TBL] [Abstract][Full Text] [Related]
30. Binding affinity and in vitro cytotoxicity of harmaline targeting different motifs of nucleic acids: An ultimate drug designing approach.
Bhattacharjee P; Ghosh T; Sarkar S; Pandya P; Bhadra K
J Mol Recognit; 2018 Apr; 31(4):. PubMed ID: 29243872
[TBL] [Abstract][Full Text] [Related]
31. Effects of harmine on transmembrane potentials of guinea-pig atrial muscle.
Carpentier RG
Br J Pharmacol; 1980 Aug; 69(4):561-4. PubMed ID: 7437641
[TBL] [Abstract][Full Text] [Related]
32. Effects of beta-carboline alkaloids on the object recognition task in mice.
Moura DJ; Rorig C; Vieira DL; Henriques JA; Roesler R; Saffi J; Boeira JM
Life Sci; 2006 Oct; 79(22):2099-104. PubMed ID: 16904699
[TBL] [Abstract][Full Text] [Related]
33. Harmine and harmaline downregulate TCDD-induced Cyp1a1 in the livers and lungs of C57BL/6 mice.
El Gendy MA; El-Kadi AO
Biomed Res Int; 2013; 2013():258095. PubMed ID: 23509697
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of Peganum harmala L. extract, harmine and harmaline against human low-density lipoprotein oxidation.
Berrougui H; Isabelle M; Cloutier M; Hmamouchi M; Khalil A
J Pharm Pharmacol; 2006 Jul; 58(7):967-74. PubMed ID: 16805957
[TBL] [Abstract][Full Text] [Related]
35. beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).
Herraiz T; González D; Ancín-Azpilicueta C; Arán VJ; Guillén H
Food Chem Toxicol; 2010 Mar; 48(3):839-45. PubMed ID: 20036304
[TBL] [Abstract][Full Text] [Related]
36. The effect of harmaline and related harmala alkaloids on ouabain-stimulated contractions of the guinea-pig ileum.
Hider RC; Smart L; Suleiman MS
Eur J Pharmacol; 1981 Apr; 71(1):87-92. PubMed ID: 7238589
[TBL] [Abstract][Full Text] [Related]
37. Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats.
Wang Y; Wang H; Zhang L; Zhang Y; Sheng Y; Deng G; Li S; Cao N; Guan H; Cheng X; Wang C
J Ethnopharmacol; 2019 Jun; 238():111866. PubMed ID: 30970283
[TBL] [Abstract][Full Text] [Related]
38. Binding of alkaloid harmalol to DNA: photophysical and calorimetric approach.
Sarkar S; Bhadra K
J Photochem Photobiol B; 2014 Jan; 130():272-80. PubMed ID: 24368411
[TBL] [Abstract][Full Text] [Related]
39. Short Communication: Evaluation of antimicrobial activities of Harmine, Harmaline, Nicotine and their complexes.
Salman S; Idrees F; Pervaiz S; Shah FH; Badshah S; Abdullah ; Usman M; Halimi SA; Idrees J
Pak J Pharm Sci; 2016 Jul; 29(4):1317-20. PubMed ID: 27393444
[TBL] [Abstract][Full Text] [Related]
40. HPLC method for the analysis of harmol, harmalol, harmine and harmaline in the seeds of Peganum harmala L.
Kartal M; Altun ML; Kurucu S
J Pharm Biomed Anal; 2003 Feb; 31(2):263-9. PubMed ID: 12609665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
